Tedicareby FastHSR

Physician

Jawad Daud, M.D.

According to 2025 Medicare claims, Jawad Daud, M.D. (NPI: 1073826368) practices addiction medicine in the Grand Forks, ND-MN market, with the plurality of this provider's patient population coming from Polk, MN. This provider's primary affiliated billing organization is ALLUMA, INC. (NPI: 1508835133; TIN: 410851371) and primary practice location at 56716-2914.

Daud's data goes back to 2015 and runs through 2024. Part D data shows 206 prescription claims across 12 beneficiaries totaling $17,499 in drug costs, led by Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

No connected Part B records

No connected Part B records

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$8.7K$17K2021 Drug cost: $947 (USD; Tot_Drug_Cst)2023 Drug cost: $2,025 (USD; Tot_Drug_Cst)2024 Drug cost: $17,499 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R11$947
2022N/RN/RN/R
2023N/R24$2,025
202412206$17,499

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl14391$2,007
Naltrexone HclNaltrexone Hcl13282$433
Quetiapine FumarateQuetiapine Fumarate16457$196
AripiprazoleAripiprazole18540$165
ClonazepamClonazepam29757$96

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Jawad Daud, M.D.?

Tedicare shows public-source Medicare data for Jawad Daud, M.D. (NPI 1073826368), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jawad Daud, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jawad Daud, M.D.?

Jawad Daud, M.D. is linked to ALLUMA, INC. (billing NPI 1508835133) in the available physician profile data.

Does Jawad Daud, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.